China SFDA To Monitor Five Roche Drugs Tied To Adverse Reactions
This article was originally published in PharmAsia News
Executive Summary
China's State FDA plans to monitor five Roche drugs in the wake of a probe launched in Europe by the European Medicines Agency into the Swiss drug maker's failure to report adverse reactions and 15,000 possibly related deaths.